Triple hit on ocular surface inflammation – case reports Case report

Article Sidebar

PDF


Published: Dec 31, 2023
DOI: https://doi.org/10.24292/01.OT.341223
Keywords:
ocular surface disease, treatment

Main Article Content

Marek E. Prost
Department of Ophthalmology, Military Institute of Aviation Medicine
http://orcid.org/0000-0002-5620-4171

Abstract

In everyday medical practice, finding the exact cause of conjunctivitis can be difficult without thorough laboratory testing. Therefore, the paper presents cases of treating ocular surface disorders of unknown etiology with the help of combination preparations in the form of a suspension, which allows a wide range of therapeutic effects including bacteria, chlamydia and allergic inflammation and provides a more stable and longer-lasting drug concentration level compared to drugs in the form of aqueous solutions.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Prost ME. Triple hit on ocular surface inflammation – case reports. Ophthatherapy [Internet]. 2023Dec.31 [cited 2024Apr.27];10(4):291-5. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/2944
Issue
Vol 10 No 4 (2023)
Section
Conservative treatment
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Narayana S, McGee S. Bedside Diagnosis of the ‘Red Eye’: A Systematic Review. Am J Med. 2015; 128(11): 1220-4.e1.
2. Jachowicz R, Czech A. Postacie leków do oczu. In: Prost M, Jachowicz R, Nowak JZ. Kliniczna Farmakologia Okulistyczna. Edra Urban & Partner, 2016: 25-72.
3. Prost M. Podstawy antybiotykoterapii schorzeń powierzchni oka. Ophthatherapy. Terapie w Okulistyce. 2014; 1(1): 26-32.
4. Prost M. Bakteryjne zapalenie spojówki i rogówki – wytyczne terapeutyczne. Ophthatherapy, Terapie w Okulistyce. 2018; 5(Supl.1): 5-9.
5. Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008; 86(1): 5-17.
6. Jefferis J, Perera R, Everitt H et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract. 2011; 61(590): e542-8.
7. Pflugfelder SC, Karpecki PM, Perez VL. Treatment of Blepharitis: Recent Clinical Trials. Ocular Surface. 2014; 12(4): 273-84.
8. Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5): 863-8. https://doi.org/10.1016/j.ophtha.2004.12.026.
9. Shirai C, Matsuoka N, Nakazawa T. Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: a retrospective non-interventional cohort study. BMC Ophthalmic. 2021; 21(1): 52. https://doi.org/10.1186/s12886-021-01813-w.